ClinicalTrials.Veeva

Menu

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Lilly logo

Lilly

Status and phase

Completed
Phase 4

Conditions

Attention Deficit Hyperactivity Disorder
Reading Disorder

Treatments

Drug: placebo
Drug: Atomoxetine Hydrochloride

Study type

Interventional

Funder types

Industry

Identifiers

NCT00191906
B4Z-MC-LYCK (Other Identifier)
7955

Details and patient eligibility

About

To test the hypothesis that a 4 week treatment with atomoxetine is more effective than placebo in patients with combined type Attention Deficit/Hyperactivity Disorder (ADHD), patients with only Reading Disorder, and patients with combined type ADHD and Reading Disorder.

Enrollment

121 patients

Sex

All

Ages

8 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis with Attention Deficit Hyperactivity Disorder and/or Reading Disorder

Exclusion criteria

  • Patients with Conduct Disorder
  • Patients who have a history of Bipolar I or II Disorder, psychosis, or Pervasive Development Disorder.
  • Patients who have a current diagnosis of Vocal Tic Disorder, Obsessive Compulsive Disorder, Major Depressive Disorder, Post Traumatic Stress Disorder, Anxiety Disorder, and certain other learning disorders.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

121 participants in 4 patient groups

Atomoxetine first, then Placebo
Experimental group
Description:
Atomoxetine, 1.2 mg/kg/day, by mouth (PO) for 4 weeks, 2 week washout period and cross-over to placebo, every day (QD), PO for 4 weeks
Treatment:
Drug: Atomoxetine Hydrochloride
Drug: placebo
Placebo first, then Atomoxetine
Experimental group
Description:
Placebo, every day (QD), by mouth (PO) for 4 weeks, 2 week washout period and cross-over to atomoxetine 1.2 mg/kg/day, PO for 4 weeks
Treatment:
Drug: Atomoxetine Hydrochloride
Drug: placebo
Normal Control
No Intervention group
Description:
Normal controls were children selected from the general population. The normal control was matched (have same proportion) by sex (male/female) and by age (have same age range) as the study population.
Reading Disordered Control
No Intervention group
Description:
The reading disordered control group is comprised of children with reading disorder who receive standard remedial teaching therapy.

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems